Compared with those before treatment, the levels of CD3+ and CD4+ and the ratio of CD4/CD8 in both groups increased significantly after treatment, indicating that long-term administration of iron proteinsuccinylate can significantly improve the immunity of children, thereby effectively reducing the incidence of complications caused by iron deficiency anemia in children. The gene discussed is CD4; the disease is Iron deficiency anemia.